Back to company

Evosep ApS: Financial statements 2023

CVR: 37510068

Evosep ApS (CVR 37510068) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 60,355,000 and a net result of DKK 19,777,000 compared with DKK -79,619,456 the year before. That is an increase of 12.8% compared with the year before. Equity amounted to DKK 252,714,000. The solvency ratio was 91.8%. The company had 42 employees in the financial year.

Gross Profit
60,355,000 kr.
Profit/Loss
19,777,000 kr.
Equity
252,714,000 kr.
Total Assets
275,300,000 kr.
Employees
42

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-60.4 mio.19.8 mio.252.7 mio.42
2022-53.5 mio.-79.6 mio.-34.4 mio.20
2021-36.9 mio.16.7 mio.45.2 mio.20
2020-21.6 mio.6.2 mio.28.5 mio.15
2019-9 mio.-141 t.22.4 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Morten Bern joins Evosep ApS as adm. dir.Oct 2, 2023

As of October 2, 2023, Morten Bern is registered as adm. dir. of Evosep ApS.

Christian Ravnsborg steps down as adm. dir. of Evosep ApSOct 2, 2023

As of October 2, 2023, Christian Ravnsborg has stepped down as adm. dir. of Evosep ApS.

Evosep ApS: The 2022 annual report is outApr 8, 2023

Evosep ApS has published its annual report for 2022. Gross profit came to DKK 53,509,833, and the net result was DKK -79,619,456.

Ole Vorm joins the board of Evosep ApSJan 3, 2023

As of January 3, 2023, Ole Vorm has joined the board of directors of Evosep ApS.

Stephen Neil van Helden joins the board of Evosep ApSJan 3, 2023

As of January 3, 2023, Stephen Neil van Helden has joined the board of directors of Evosep ApS.

Ole Vorm leaves the board of Evosep ApSJan 2, 2023

As of January 2, 2023, Ole Vorm has left the board of directors of Evosep ApS.

About Evosep ApS

Evosep ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Omics Ready Biosystems ApS. The management consists of Morten Bern. The company is owned by Paradigm BidCo ApS. The company has 16 employees. In 2025, the company reported a gross profit of DKK 72,369,000 and a net result of DKK -221,637,000 compared with DKK -2,613,000 the year before. Equity amounted to DKK 154,548,000.